The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma
The HTP and TTP groups were safe and effective compared to TACE alone for the treatment of recurrent unresectable hepatocellular carcinoma, and the HTP group demonstrated a superior CR.
Authors
- Minglong Wang (ORCID: https://orcid.org/0000-0003-0141-7281)
- Xian Ge
- Guoqing Zhu (ORCID: https://orcid.org/0000-0002-2731-2018)
- Wei Deng (ORCID: https://orcid.org/0009-0002-9468-9234)
- Bin Yu (ORCID: https://orcid.org/0000-0002-0397-6610)
- Yongqiang Xiao (ORCID: https://orcid.org/0000-0003-2626-9182)
- Laihui Luo (ORCID: https://orcid.org/0000-0003-3351-2187)
- Jin Xie (ORCID: https://orcid.org/0000-0002-8915-6233)
- Rong-guang Luo
- Tao Wang (ORCID: https://orcid.org/0000-0003-1118-9876)
- Renfeng Shan (ORCID: https://orcid.org/0000-0001-5016-7448)
- Renhua Wan
- Zhigao Hu (ORCID: https://orcid.org/0000-0003-0575-2191)
- Wu Wen
- Jiahao Tao (ORCID: https://orcid.org/0000-0001-8950-3613)
- Yang Liu (ORCID: https://orcid.org/0000-0002-9442-700X)
- Liucong Lin
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1186/s12885-025-14185-x
- Citations
- 3
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.97
Funders
- Nanchang University